 | • レポートコード：MRC2012B1590 • 出版社/出版日：GlobalInfoResearch / 2020年12月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、潰瘍性大腸炎の世界市場を広く調査・分析し、今後の市場展望をまとめております。潰瘍性大腸炎の種類別市場規模（経口、注射）、用途別市場規模（病院、ドラッグストア）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Johnson & Johnson.、Ferring Pharmaceuticals、Roche、AbbVie、Takeda、Takeda Pharmaceuticals、InDeX Pharmaceuticals、Salix Pharmaceuticals/Santarus、Warner Chilcott、Pfizer、 ・地域別グローバル市場分析 2015年-2020年 ・潰瘍性大腸炎の北米市場（アメリカ、カナダ、メキシコ） ・潰瘍性大腸炎のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・潰瘍性大腸炎のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・潰瘍性大腸炎の南米市場（ブラジル、アルゼンチン） ・潰瘍性大腸炎の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：経口、注射 ・用途別分析：病院、ドラッグストア ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Ulcerative Colitis market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Ulcerative Colitis market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Ulcerative Colitis market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Ulcerative Colitis market has been segmented into:
Oral
Injection
By Application, Ulcerative Colitis has been segmented into:
Hospital
Drugs Stores
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Ulcerative Colitis market presented in the report. This section sheds light on the sales growth of different regional and country-level Ulcerative Colitis markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Ulcerative Colitis market.
The report offers in-depth assessment of the growth and other aspects of the Ulcerative Colitis market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Ulcerative Colitis Market Share Analysis
Ulcerative Colitis competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Ulcerative Colitis sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Ulcerative Colitis sales, revenue and market share for each player covered in this report.
The major players covered in Ulcerative Colitis are:
Johnson & Johnson.
Ferring Pharmaceuticals
Roche
AbbVie
Takeda
Takeda Pharmaceuticals
InDeX Pharmaceuticals
Salix Pharmaceuticals/Santarus
Warner Chilcott
Pfizer
Table of Contents
1 Ulcerative Colitis Market Overview
1.1 Product Overview and Scope of Ulcerative Colitis
1.2 Classification of Ulcerative Colitis by Type
1.2.1 Global Ulcerative Colitis Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Ulcerative Colitis Revenue Market Share by Type in 2019
1.2.3 Oral
1.2.4 Injection
1.3 Global Ulcerative Colitis Market by Application
1.3.1 Overview: Global Ulcerative Colitis Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Drugs Stores
1.4 Global Ulcerative Colitis Market by Regions
1.4.1 Global Ulcerative Colitis Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Ulcerative Colitis (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Ulcerative Colitis Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Ulcerative Colitis Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Ulcerative Colitis Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Ulcerative Colitis Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Ulcerative Colitis Status and Prospect (2015-2025)
2 Company Profiles
2.1 Johnson & Johnson.
2.1.1 Johnson & Johnson. Details
2.1.2 Johnson & Johnson. Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Johnson & Johnson. SWOT Analysis
2.1.4 Johnson & Johnson. Product and Services
2.1.5 Johnson & Johnson. Ulcerative Colitis Revenue, Gross Margin and Market Share (2018-2019)
2.2 Ferring Pharmaceuticals
2.2.1 Ferring Pharmaceuticals Details
2.2.2 Ferring Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Ferring Pharmaceuticals SWOT Analysis
2.2.4 Ferring Pharmaceuticals Product and Services
2.2.5 Ferring Pharmaceuticals Ulcerative Colitis Revenue, Gross Margin and Market Share (2018-2019)
2.3 Roche
2.3.1 Roche Details
2.3.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Roche SWOT Analysis
2.3.4 Roche Product and Services
2.3.5 Roche Ulcerative Colitis Revenue, Gross Margin and Market Share (2018-2019)
2.4 AbbVie
2.4.1 AbbVie Details
2.4.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 AbbVie SWOT Analysis
2.4.4 AbbVie Product and Services
2.4.5 AbbVie Ulcerative Colitis Revenue, Gross Margin and Market Share (2018-2019)
2.5 Takeda
2.5.1 Takeda Details
2.5.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Takeda SWOT Analysis
2.5.4 Takeda Product and Services
2.5.5 Takeda Ulcerative Colitis Revenue, Gross Margin and Market Share (2018-2019)
2.6 Takeda Pharmaceuticals
2.6.1 Takeda Pharmaceuticals Details
2.6.2 Takeda Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Takeda Pharmaceuticals SWOT Analysis
2.6.4 Takeda Pharmaceuticals Product and Services
2.6.5 Takeda Pharmaceuticals Ulcerative Colitis Revenue, Gross Margin and Market Share (2018-2019)
2.7 InDeX Pharmaceuticals
2.7.1 InDeX Pharmaceuticals Details
2.7.2 InDeX Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 InDeX Pharmaceuticals SWOT Analysis
2.7.4 InDeX Pharmaceuticals Product and Services
2.7.5 InDeX Pharmaceuticals Ulcerative Colitis Revenue, Gross Margin and Market Share (2018-2019)
2.8 Salix Pharmaceuticals/Santarus
2.8.1 Salix Pharmaceuticals/Santarus Details
2.8.2 Salix Pharmaceuticals/Santarus Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Salix Pharmaceuticals/Santarus SWOT Analysis
2.8.4 Salix Pharmaceuticals/Santarus Product and Services
2.8.5 Salix Pharmaceuticals/Santarus Ulcerative Colitis Revenue, Gross Margin and Market Share (2018-2019)
2.9 Warner Chilcott
2.9.1 Warner Chilcott Details
2.9.2 Warner Chilcott Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Warner Chilcott SWOT Analysis
2.9.4 Warner Chilcott Product and Services
2.9.5 Warner Chilcott Ulcerative Colitis Revenue, Gross Margin and Market Share (2018-2019)
2.10 Pfizer
2.10.1 Pfizer Details
2.10.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Pfizer SWOT Analysis
2.10.4 Pfizer Product and Services
2.10.5 Pfizer Ulcerative Colitis Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Ulcerative Colitis Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Ulcerative Colitis Players Market Share
3.2.2 Top 10 Ulcerative Colitis Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Ulcerative Colitis Revenue and Market Share by Regions
4.2 North America Ulcerative Colitis Revenue and Growth Rate (2015-2020)
4.3 Europe Ulcerative Colitis Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Ulcerative Colitis Revenue and Growth Rate (2015-2020)
4.5 South America Ulcerative Colitis Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Ulcerative Colitis Revenue and Growth Rate (2015-2020)
5 North America Ulcerative Colitis Revenue by Countries
5.1 North America Ulcerative Colitis Revenue by Countries (2015-2020)
5.2 USA Ulcerative Colitis Revenue and Growth Rate (2015-2020)
5.3 Canada Ulcerative Colitis Revenue and Growth Rate (2015-2020)
5.4 Mexico Ulcerative Colitis Revenue and Growth Rate (2015-2020)
6 Europe Ulcerative Colitis Revenue by Countries
6.1 Europe Ulcerative Colitis Revenue by Countries (2015-2020)
6.2 Germany Ulcerative Colitis Revenue and Growth Rate (2015-2020)
6.3 UK Ulcerative Colitis Revenue and Growth Rate (2015-2020)
6.4 France Ulcerative Colitis Revenue and Growth Rate (2015-2020)
6.5 Russia Ulcerative Colitis Revenue and Growth Rate (2015-2020)
6.6 Italy Ulcerative Colitis Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Ulcerative Colitis Revenue by Countries
7.1 Asia-Pacific Ulcerative Colitis Revenue by Countries (2015-2020)
7.2 China Ulcerative Colitis Revenue and Growth Rate (2015-2020)
7.3 Japan Ulcerative Colitis Revenue and Growth Rate (2015-2020)
7.4 Korea Ulcerative Colitis Revenue and Growth Rate (2015-2020)
7.5 India Ulcerative Colitis Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Ulcerative Colitis Revenue and Growth Rate (2015-2020)
8 South America Ulcerative Colitis Revenue by Countries
8.1 South America Ulcerative Colitis Revenue by Countries (2015-2020)
8.2 Brazil Ulcerative Colitis Revenue and Growth Rate (2015-2020)
8.3 Argentina Ulcerative Colitis Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Ulcerative Colitis by Countries
9.1 Middle East & Africa Ulcerative Colitis Revenue by Countries (2015-2020)
9.2 Saudi Arabia Ulcerative Colitis Revenue and Growth Rate (2015-2020)
9.3 UAE Ulcerative Colitis Revenue and Growth Rate (2015-2020)
9.4 Egypt Ulcerative Colitis Revenue and Growth Rate (2015-2020)
9.5 South Africa Ulcerative Colitis Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Ulcerative Colitis Revenue and Market Share by Type (2015-2020)
10.2 Global Ulcerative Colitis Market Forecast by Type (2019-2024)
10.3 Oral Revenue Growth Rate (2015-2025)
10.4 Injection Revenue Growth Rate (2015-2025)
11 Global Ulcerative Colitis Market Segment by Application
11.1 Global Ulcerative Colitis Revenue Market Share by Application (2015-2020)
11.2 Ulcerative Colitis Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Drugs Stores Revenue Growth (2015-2020)
12 Global Ulcerative Colitis Market Size Forecast (2021-2025)
12.1 Global Ulcerative Colitis Market Size Forecast (2021-2025)
12.2 Global Ulcerative Colitis Market Forecast by Regions (2021-2025)
12.3 North America Ulcerative Colitis Revenue Market Forecast (2021-2025)
12.4 Europe Ulcerative Colitis Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Ulcerative Colitis Revenue Market Forecast (2021-2025)
12.6 South America Ulcerative Colitis Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Ulcerative Colitis Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Ulcerative Colitis Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Ulcerative Colitis by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Ulcerative Colitis Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Ulcerative Colitis Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Johnson & Johnson. Corporate Information, Location and Competitors
Table 6. Johnson & Johnson. Ulcerative Colitis Major Business
Table 7. Johnson & Johnson. Ulcerative Colitis Total Revenue (USD Million) (2017-2018)
Table 8. Johnson & Johnson. SWOT Analysis
Table 9. Johnson & Johnson. Ulcerative Colitis Product and Solutions
Table 10. Johnson & Johnson. Ulcerative Colitis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Ferring Pharmaceuticals Corporate Information, Location and Competitors
Table 12. Ferring Pharmaceuticals Ulcerative Colitis Major Business
Table 13. Ferring Pharmaceuticals Ulcerative Colitis Total Revenue (USD Million) (2018-2019)
Table 14. Ferring Pharmaceuticals SWOT Analysis
Table 15. Ferring Pharmaceuticals Ulcerative Colitis Product and Solutions
Table 16. Ferring Pharmaceuticals Ulcerative Colitis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Roche Corporate Information, Location and Competitors
Table 18. Roche Ulcerative Colitis Major Business
Table 19. Roche Ulcerative Colitis Total Revenue (USD Million) (2017-2018)
Table 20. Roche SWOT Analysis
Table 21. Roche Ulcerative Colitis Product and Solutions
Table 22. Roche Ulcerative Colitis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. AbbVie Corporate Information, Location and Competitors
Table 24. AbbVie Ulcerative Colitis Major Business
Table 25. AbbVie Ulcerative Colitis Total Revenue (USD Million) (2017-2018)
Table 26. AbbVie SWOT Analysis
Table 27. AbbVie Ulcerative Colitis Product and Solutions
Table 28. AbbVie Ulcerative Colitis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Takeda Corporate Information, Location and Competitors
Table 30. Takeda Ulcerative Colitis Major Business
Table 31. Takeda Ulcerative Colitis Total Revenue (USD Million) (2017-2018)
Table 32. Takeda SWOT Analysis
Table 33. Takeda Ulcerative Colitis Product and Solutions
Table 34. Takeda Ulcerative Colitis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Takeda Pharmaceuticals Corporate Information, Location and Competitors
Table 36. Takeda Pharmaceuticals Ulcerative Colitis Major Business
Table 37. Takeda Pharmaceuticals Ulcerative Colitis Total Revenue (USD Million) (2017-2018)
Table 38. Takeda Pharmaceuticals SWOT Analysis
Table 39. Takeda Pharmaceuticals Ulcerative Colitis Product and Solutions
Table 40. Takeda Pharmaceuticals Ulcerative Colitis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. InDeX Pharmaceuticals Corporate Information, Location and Competitors
Table 42. InDeX Pharmaceuticals Ulcerative Colitis Major Business
Table 43. InDeX Pharmaceuticals Ulcerative Colitis Total Revenue (USD Million) (2017-2018)
Table 44. InDeX Pharmaceuticals SWOT Analysis
Table 45. InDeX Pharmaceuticals Ulcerative Colitis Product and Solutions
Table 46. InDeX Pharmaceuticals Ulcerative Colitis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Salix Pharmaceuticals/Santarus Corporate Information, Location and Competitors
Table 48. Salix Pharmaceuticals/Santarus Ulcerative Colitis Major Business
Table 49. Salix Pharmaceuticals/Santarus Ulcerative Colitis Total Revenue (USD Million) (2017-2018)
Table 50. Salix Pharmaceuticals/Santarus SWOT Analysis
Table 51. Salix Pharmaceuticals/Santarus Ulcerative Colitis Product and Solutions
Table 52. Salix Pharmaceuticals/Santarus Ulcerative Colitis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Warner Chilcott Corporate Information, Location and Competitors
Table 54. Warner Chilcott Ulcerative Colitis Major Business
Table 55. Warner Chilcott Ulcerative Colitis Total Revenue (USD Million) (2017-2018)
Table 56. Warner Chilcott SWOT Analysis
Table 57. Warner Chilcott Ulcerative Colitis Product and Solutions
Table 58. Warner Chilcott Ulcerative Colitis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Pfizer Corporate Information, Location and Competitors
Table 60. Pfizer Ulcerative Colitis Major Business
Table 61. Pfizer Ulcerative Colitis Total Revenue (USD Million) (2017-2018)
Table 62. Pfizer SWOT Analysis
Table 63. Pfizer Ulcerative Colitis Product and Solutions
Table 64. Pfizer Ulcerative Colitis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Ulcerative Colitis Revenue (Million USD) by Players (2015-2020)
Table 66. Global Ulcerative Colitis Revenue Share by Players (2015-2020)
Table 67. Global Ulcerative Colitis Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Ulcerative Colitis Revenue Market Share by Regions (2015-2020)
Table 69. North America Ulcerative Colitis Revenue by Countries (2015-2020)
Table 70. North America Ulcerative Colitis Revenue Market Share by Countries (2015-2020)
Table 71. Europe Ulcerative Colitis Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Ulcerative Colitis Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Ulcerative Colitis Revenue by Countries (2015-2020)
Table 74. South America Ulcerative Colitis Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Ulcerative Colitis Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Ulcerative Colitis Revenue Market Share by Countries (2015-2020)
Table 77. Global Ulcerative Colitis Revenue (Million USD) by Type (2015-2020)
Table 78. Global Ulcerative Colitis Revenue Share by Type (2015-2020)
Table 79. Global Ulcerative Colitis Revenue Forecast by Type (2021-2025)
Table 80. Global Ulcerative Colitis Revenue by Application (2015-2020)
Table 81. Global Ulcerative Colitis Revenue Share by Application (2015-2020)
Table 82. Global Ulcerative Colitis Revenue Forecast by Application (2021-2025)
Table 83. Global Ulcerative Colitis Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Ulcerative Colitis Picture
Figure 2. Global Ulcerative Colitis Revenue Market Share by Type in 2019
Figure 3. Oral Picture
Figure 4. Injection Picture
Figure 5. Ulcerative Colitis Revenue Market Share by Application in 2019
Figure 6. Hospital Picture
Figure 7. Drugs Stores Picture
Figure 8. Global Ulcerative Colitis Revenue (USD Million) and Growth Rate (2015-2025)
Figure 9. North America Ulcerative Colitis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 10. Europe Ulcerative Colitis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Asia-Pacific Ulcerative Colitis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. South America Ulcerative Colitis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Middle East and Africa Ulcerative Colitis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Global Ulcerative Colitis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Ulcerative Colitis Revenue Share by Players in 2019
Figure 16. Global Top 5 Players Ulcerative Colitis Revenue Market Share in 2019
Figure 17. Global Top 10 Players Ulcerative Colitis Revenue Market Share in 2019
Figure 18. Key Players Market Share Trend
Figure 19. Global Ulcerative Colitis Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 20. Global Ulcerative Colitis Revenue Market Share by Regions (2015-2020)
Figure 21. Global Ulcerative Colitis Revenue Market Share by Regions in 2018
Figure 22. North America Ulcerative Colitis Revenue and Growth Rate (2015-2020)
Figure 23. Europe Ulcerative Colitis Revenue and Growth Rate (2015-2020)
Figure 24. Asia-Pacific Ulcerative Colitis Revenue and Growth Rate (2015-2020)
Figure 25. South America Ulcerative Colitis Revenue and Growth Rate (2015-2020)
Figure 26. Middle East and Africa Ulcerative Colitis Revenue and Growth Rate (2015-2020)
Figure 27. North America Ulcerative Colitis Revenue Market Share by Countries (2015-2020)
Figure 28. North America Ulcerative Colitis Revenue Market Share by Countries in 2019
Figure 29. USA Ulcerative Colitis Revenue and Growth Rate (2015-2020)
Figure 30. Canada Ulcerative Colitis Revenue and Growth Rate (2015-2020)
Figure 31. Mexico Ulcerative Colitis Revenue and Growth Rate (2015-2020)
Figure 32. Europe Ulcerative Colitis Revenue Market Share by Countries (2015-2020)
Figure 33. Europe Ulcerative Colitis Revenue Market Share by Countries in 2019
Figure 34. Germany Ulcerative Colitis Revenue and Growth Rate (2015-2020)
Figure 35. UK Ulcerative Colitis Revenue and Growth Rate (2015-2020)
Figure 36. France Ulcerative Colitis Revenue and Growth Rate (2015-2020)
Figure 37. Russia Ulcerative Colitis Revenue and Growth Rate (2015-2020)
Figure 38. Italy Ulcerative Colitis Revenue and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Ulcerative Colitis Revenue Market Share by Countries (2015-2020)
Figure 40. Asia-Pacific Ulcerative Colitis Revenue Market Share by Countries in 2019
Figure 41. China Ulcerative Colitis Revenue and Growth Rate (2015-2020)
Figure 42. Japan Ulcerative Colitis Revenue and Growth Rate (2015-2020)
Figure 43. Korea Ulcerative Colitis Revenue and Growth Rate (2015-2020)
Figure 44. India Ulcerative Colitis Revenue and Growth Rate (2015-2020)
Figure 45. Southeast Asia Ulcerative Colitis Revenue and Growth Rate (2015-2020)
Figure 46. South America Ulcerative Colitis Revenue Market Share by Countries (2015-2020)
Figure 47. South America Ulcerative Colitis Revenue Market Share by Countries in 2019
Figure 48. Brazil Ulcerative Colitis Revenue and Growth Rate (2015-2020)
Figure 49. Argentina Ulcerative Colitis Revenue and Growth Rate (2015-2020)
Figure 50. Middle East and Africa Ulcerative Colitis Revenue Market Share by Countries (2015-2020)
Figure 51. Middle East and Africa Ulcerative Colitis Revenue Market Share by Countries in 2019
Figure 52. Saudi Arabia Ulcerative Colitis Revenue and Growth Rate (2015-2020)
Figure 53. UAE Ulcerative Colitis Revenue and Growth Rate (2015-2020)
Figure 54. Egypt Ulcerative Colitis Revenue and Growth Rate (2015-2020)
Figure 55. South Africa Ulcerative Colitis Revenue and Growth Rate (2015-2020)
Figure 56. Global Ulcerative Colitis Revenue Share by Type (2015-2020)
Figure 57. Global Ulcerative Colitis Revenue Share by Type in 2019
Figure 58. Global Ulcerative Colitis Market Share Forecast by Type (2021-2025)
Figure 59. Global Oral Revenue Growth Rate (2015-2020)
Figure 60. Global Injection Revenue Growth Rate (2015-2020)
Figure 61. Global Ulcerative Colitis Revenue Share by Application (2015-2020)
Figure 62. Global Ulcerative Colitis Revenue Share by Application in 2019
Figure 63. Global Ulcerative Colitis Market Share Forecast by Application (2021-2025)
Figure 64. Global Hospital Revenue Growth Rate (2015-2020)
Figure 65. Global Drugs Stores Revenue Growth Rate (2015-2020)
Figure 66. Global Ulcerative Colitis Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 67. Global Ulcerative Colitis Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 68. Global Ulcerative Colitis Revenue Market Share Forecast by Regions (2021-2025)
Figure 69. North America Ulcerative Colitis Revenue Market Forecast (2021-2025)
Figure 70. Europe Ulcerative Colitis Revenue Market Forecast (2021-2025)
Figure 71. Asia-Pacific Ulcerative Colitis Revenue Market Forecast (2021-2025)
Figure 72. South America Ulcerative Colitis Revenue Market Forecast (2021-2025)
Figure 73. Middle East and Africa Ulcerative Colitis Revenue Market Forecast (2021-2025)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
潰瘍性大腸炎治療薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Drug for Ulcerative Colitis market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Drug for Ulcerati…- 潰瘍性大腸炎免疫治療薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Ulcerative Colitis Immunology Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Ulcerativ…
- 潰瘍性大腸炎免疫薬 の世界市場（～2026年） Market Analysis and Insights: Global Ulcerative Colitis Immunology Drugs Market The global Ulcerative Colitis Immunology Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Ulcerative Colitis Immunology Drugs Scope a…
- 潰瘍性大腸炎治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Ulcerative Colitis Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Ulcerative Colit…
- レミケード（インフリキシマブ）医薬品の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Remicade (infliximab) Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Remicade (inflixim…